HCV and HBV testing acceptability and knowledge among urban emergency department patients and pharmacy clients

Calderon, Yvette; Cowan, Ethan; Schramm, Christopher; Stern, Sam; Brusalis, Christopher M.; Iscoe, Mark; Rahman, Sara; Verma, Rajesh; Leider, Jason

doi:10.1016/j.ypmed.2013.12.026

Cited by 8 publications

(8 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…To meet the WHO goal of identifying 90% of all HCVinfected individuals, PoC testing needs to be implemented into nontraditional settings to capture individuals not actively engaged in health care, including emergency departments, obstetric centers, surgical and psychiatric wards, dental clinics, and pharmacies. [36][37][38][39][40][41] Potential benefits of increased PoC testing include reducing the number of clinic visits, which may increase screening and treatment rates, and reducing late presentation, which is common in patients with HCV. 42 Using DBS samples is an alternative method to PoC testing.…”

Section: Virologic Tools To Simplify Hcv Screeningmentioning

confidence: 99%

Simplification of Care for Chronic Hepatitis C Virus Infection

et al. 2020

View full text Add to dashboard Cite

In 2016, the World Health Organization (WHO) set a target for eliminating viral hepatitis as a major public health threat by 2030. However, while today's highly effective and well-tolerated pangenotypic direct-acting antiviral regimens have maximized simplification of hepatitis C virus (HCV) treatment, there remain a plethora of barriers to HCV screening, diagnosis, and linkage to care. As of 2017, only 19% of the estimated 71 million individuals living with chronic HCV worldwide were diagnosed and in 2015 to 2016, only 21% of diagnosed individuals had accessed treatment. Simplification and decentralization of the HCV care cascade would bolster patient engagement and support the considerable scale-up needed to achieve WHO targets. Recent developments in HCV screening and diagnosis, together with reduced pretreatment assessment and on-treatment monitoring requirements, can further streamline the care continuum, ensuring patients are linked to care quickly and earlier in the disease course, and minimize clinic visits.

show abstract

Section: Virologic Tools To Simplify Hcv Screeningmentioning

confidence: 99%

Simplification of Care for Chronic Hepatitis C Virus Infection

et al. 2020

View full text Add to dashboard Cite

show abstract

“…Para evaluar el efecto de la educación proporcionada por el farmacéutico en el conocimiento del paciente o de los profesionales de la salud, puede realizarse un cuestionario antes y después de la educación que incluye temas como mecanismo de transmisión, tratamiento y reacciones adversas, con el fin de determinar el estado inicial y final de conocimientos sobre el VHC (7,17).…”

Section: Evaluación De Conocimientos En Vhcunclassified

Rol del farmacéutico en la atención integral de pacientes con hepatitis C: revisión sistemática

Morales

Salazar-Ospina

Amariles

et al. 2020

Rev Colomb Gastroenterol

View full text Add to dashboard Cite

Objetivo: Identificar y caracterizar las acciones/intervenciones realizadas desde los servicios farmacéuticos en el abordaje de pacientes con Hepatitis C y proponer una vía clínica para la gestión de la enfermedad que incluya la participación del farmacéutico. Método: Revisión sistemática en PubMed y EMBASE empleando los términos "Hepatitis C", "Pharmaceutical Services", "Community Pharmacy Services", y "Pharmacies"; artículos publicados hasta el 31 de marzo de 2019, cuyo tema central fueran las actividades realizadas por los servicios farmacéuticos en la atención a pacientes con Hepatitis C. Se recopiló información sobre: actividad realizada, responsable, si la intervención era individual o colectiva y el entorno de aplicación. Las actividades se agruparon en: promoción y prevención, gestión administrativa, atención farmacéutica, investigación y otros servicios de apoyo. De acuerdo a esto, se propuso una vía clínica para el manejo de la Hepatitis C con participación del farmacéutico. Resultados: se incluyeron 60 artículos, principalmente de estudios descriptivos. La mayoria de las publicaciones reportaron intervenciones realizadas en Estados Unidos y España. Se identificó la participación del personal farmacéutico en cada una de las etapas del proceso de atención, incluyendo: provisión de servicios de reducción del daño, tamizaje del Virus de la Hepatitis C, vinculación de los pacientes al tratamiento, prescripción de medicamentos y órdenes de laboratorio. Conclusiones: Se identifican y caracterizan las acciones/intervenciones realizadas desde el servicio farmacéutico para el manejo de la Hepatitis C y se propone una vía clínica en la que se integran los servicios profesionales farmacéuticos a las demás actividades de la atención del paciente.

show abstract

“…25,26 Additionally, new point-of-care tests have been used to identify specific infectious diseases, including viral hepatitis and HIV infection. [27][28][29][30] Spirometry testing aids in recognizing and managing asthma and chronic obstructive pulmonary disease. [31][32][33] Colleges and schools of pharmacy have already described and implemented content and coursework on the principles of clinical reasoning.…”

Section: The New Competencies For Diagnosis Align With the Existing Pmentioning

confidence: 99%

Pharmacy Education Needs to Address Diagnostic Safety

Graber

Grice

Ling

et al. 2019

American Journal of Pharmaceutical Education

View full text Add to dashboard Cite

The American Association of Colleges of Pharmacy, the Accreditation Council for Pharmacy Education, and the Center for the Advancement of Pharmacy Education frame patient safety from the perspective of medication management, which is also the current focus of pharmacy education and training. With the growing appreciation that diagnostic errors represent an urgent and actionable patient safety concern, the National Academy of Medicine has recommended diagnostic safety training for all health care professions. The Society to Improve Diagnosis in Medicine has worked with an interprofessional consensus group to identify a set of 12 key competencies necessary to achieve diagnostic quality and safety that focuses on individual, team-based, and system-related competencies. Much of this already exists in pharmacy education, but pharmacy training programs need to give graduates more guidance on how they contribute to the diagnostic process and the prevention and detection of diagnostic errors. We describe the current state of progress in this regard, and what steps are needed by training programs to provide content and assessment so that graduates achieve the requisite competencies. Governing and advisory bodies need to expand the expectations around patient safety to include diagnostic safety.

show abstract

HCV and HBV testing acceptability and knowledge among urban emergency department patients and pharmacy clients

Cited by 8 publications

References 28 publications

Simplification of Care for Chronic Hepatitis C Virus Infection

Simplification of Care for Chronic Hepatitis C Virus Infection

Rol del farmacéutico en la atención integral de pacientes con hepatitis C: revisión sistemática

Pharmacy Education Needs to Address Diagnostic Safety

Contact Info

Product

Resources

About